ERBB2 and breast neoplasm: Since Rac and Cdc42-regulated MDSCs are known to exert immunosuppressive effects in the TME (41, 42, 53), we quantitated the MDSCs in SCID mice bearing HER2++ breast tumors following MBQ-167 treatment.